Quest Partners LLC Cytokinetics Inc Transaction History
Quest Partners LLC
- $1.02 Trillion
- Q2 2025
A detailed history of Quest Partners LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Quest Partners LLC holds 4,919 shares of CYTK stock, worth $172,853. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,919
Previous 6,650
26.03%
Holding current value
$172,853
Previous $267 Million
39.19%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
394Shares Held
126MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$516 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$416 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$350 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$281 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$214 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.31B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...